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Abstract.  The leukocyte function-associated molecule 
1 (LFA-1,  CDlla/CD18)  is a  membrane glycoprotein 
which functions in cell-cell adhesion by heterophilic 
interaction with intercellular adhesion molecule 1 
(ICAM-1).  LFA-1 consists of an ot subunit (Mr  = 
180,000)  and a  ~  subunit (Mr  =  95,000).  We report 
the molecular biology and protein sequence of the a 
subunit. Overlapping cDNAs containing 5,139  nucleo- 
tides were isolated using an oligonucleotide specified 
by tryptic peptide sequence. The mRNA of 5.5 kb is 
expressed in lymphoid and myeloid cells but not 
in a  bladder carcinoma cell line. The protein has a 
1,063-amino acid extracellular domain, a  29-amino 
acid transmembrane region, and a  53-amino acid cyto- 
plasmic tail. The extracellular domain contains seven 
repeats.  Repeats V-VII are in tandem and contain puta- 
tive divalent cation binding sites.  LFA-1 has significant 
homology to the members of the integrin superfamily, 
having 36%  identity with the Mac-1  and p150,95  oL 
subunits and 28%  identity with other integrin c~ 
subunits. An insertion of ~  200 amino acids is present 
in the NH2-terminal region of LFA-1. This "inserted/ 
interactive" or I domain is also present in the p150,95 
and Mac-1  o~ subunits but is absent from other integrin 
o~ subunits sequenced to date. The I domain has strik- 
ing homology to three repeats in human von 
Willebrand factor, two repeats in chicken cartilage ma- 
trix protein, and a  region of complement factor B. 
These structural features indicate a bipartite evolution 
from the integrin family and from an I domain family. 
These features may also correspond to relevant func- 
tional domains. 
T 
HE  leukocyte function-associated  1  (LFA-1)' mole- 
cule is a member of a family of three leukocyte glyco- 
proteins involved in cell-cell adhesion.  This family 
of proteins,  LFA-1, Mac-l,  and p150,95,  are heterodimers 
consisting of distinct ct subunits (Mr  =  180,000, 170,000, 
and 150,000, respectively) and a common fl subunit (Mr  = 
95,000)  (25,  47).  NH2-terminal  sequencing of the c~ sub- 
units in the mouse and human has suggested that they are 
structurally related (33, 48);  however,  the cell surface ex- 
pression and function of these molecules differs. LFA-1 is ex- 
pressed on virtually all leukocytes and is involved in a large 
number of adhesion-dependent phenomena, mAb directed 
against LFA-1 inhibit antigen-specific T helper cell function 
and cytolytic functions such as cytotoxic T lymphocyte-me- 
diated  killing,  antibody-dependent cytoxicity by  granulo- 
cytes, and natural killer activity (47).  LFA-1 is also involved 
1. Abbreviations used in this paper: CME cartilage matrix protein; ECM, 
extracellular  matrix;  FNR,  fibronectin  receptor;  ICAM-1,  intracellular 
adhesion  molecule-l;  LFA,  leukocyte  function-associated  1;  vWE  von 
Willebrand factor. 
in antigen-independent interactions that mediate cell local- 
ization to sites of inflammation such as leukocyte adhesion 
to endothelial cells, fibroblasts, epidermal keratinocytes, and 
synovial cells (12-14,  17,  30,  53).  Mac-1  and p150,95  are 
expressed on monocytes, granulocytes, and some activated 
lymphocytes, and function as adhesion molecules in cell- 
cell and cell-substrate interactions as well as complement 
receptors for C3bi (1). 
The importance of these three glycoproteins is signified by 
the  clinical syndrome known as  leukocyte adhesion defi- 
ciency (LAD) (1). The primary defect in LAD occurs in the 
fl subunit common to LFA-1, Mac-l, and p150,95 (22) result- 
ing  in deficient surface expression of the  o~fl complexes. 
LAD patients have recurrent bacterial infections which are 
sometimes fatal and their leukocytes are deficient in a wide 
range of adhesion-dependent functions. 
The structure of the fl subunit common to LFA-1, Mac-l, 
and p150,95 has been determined (23, 27) and has revealed 
homology to extracellular matrix (ECM) receptors.  These 
similarities led to the concept of a family of ~/{3 heterodimers 
designated the integrins (21, 41). The term "integrin" empha- 
sizes the role of these proteins as transmembrane links be- 
tween the extracellular environment and the cytoskeleton. 
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subunits.  The  /$~  subunit  is  common  to  the  fibronectin 
receptor (FNR) and some antigens appearing very late in leu- 
kocyte activation whereas/$3 is common to platelet glyco- 
protein IIb/IIIa (gplIb/IIIa) and the vitronectin receptor./$j 
and/$3 integrins are all ECM receptors and are involved in 
cell-substrate adhesion, matrix assembly, regulation of cell 
growth, differentiation, and localization during morphogen- 
esis, and wound healing. We will refer to the/~ and/$3 fam- 
ily as  the  extracellular matrix  receptor  integrins.  The  152 
subunit is common to LFA-1, Mac-l, and p150,95, whose ex- 
pression is limited to leukocytes, and we designate these as 
the leukocyte integrins. 
The ligand of LFA-1 is an inducible cell surface glycopro- 
tein,  intercellular  adhesion  molecule-1  (ICAM-1)  (Mr  = 
90,000),  which is found on cells of many lineages including 
leukocytes, endothelial cells, fibroblasts, and epidermal ker- 
atinocytes (14, 29, 40, 46, 49). ICAM-1 mRNA and surface 
expression is induced by inflammatory mediators including 
interferon-gamma, interleukin-1,  tumor necrosis factor, and 
lipopolysaccharide (36, 46, 49); thus, it may regulate cell in- 
teraction and localization in inflammation. LFA-l-dependent 
adhesion  of cells  to  planar  lipid  membranes  containing 
ICAM-1 requires metabolic energy, a functional cytoskele- 
ton, and divalent cations (29).  Cell activation can enhance 
LFA-l-dependent adhesion without any effect on LFA-1 or 
ICAM-1  surface expression as shown by phorbol ester-in- 
duced homotypic adhesion of B, T, and monocytic cells (39). 
ICAM-1  is a  member of the immunoglobulin superfamily 
and consists of five immunoglobulin constant region-like do- 
mains. In contrast to most ligands of the ECM receptor inte- 
grins which contain the critical recognition sequence argi- 
nine-glycine-aspartic acid (RGD), ICAM-1 does not contain 
an RGD sequence (46, 49).  The LFA-I-ICAM-1  receptor- 
ligand pair is thus far the only known example of a member 
of the integrin superfamily interacting with a member of the 
immunoglobulin superfamily. 
We have been interested in the structural basis for the im- 
portant function of LFA-1 in inflammation and the immune 
response. Furthermore, we wished to define the relationship 
of LFA-1 to other leukocyte integrins and to the ECM recep- 
tor integrins. The lack of an RGD sequence in ICAM-1 raised 
the question of whether the LFA-1 ot subunit has structural 
features typical of ECM integrins or whether novel features 
consistent with the lack of RGD recognition exist. Therefore, 
we have characterized the LFA-1 ot subunit at the protein and 
mRNA level  and have determined its  complete sequence. 
The amino acid sequence demonstrates that LFA-1 is an inte- 
gral membrane protein containing an extracellular domain, 
a  single hydrophobic transmembrane domain, and a  cyto- 
plasmic tail. The extracellular domain has seven repeats; the 
three repeats located most COOH-terminal contain putative 
divalent cation binding sites. LFA-1 has significant  homology 
with the other members of the integrin superfamily. A region 
near the NH2 terminus of the molecule contains an inser- 
tion of ,v200 amino acids similar to p150,95 (9) and Mac-1 
(4, 7, 38). This domain has significant homology to the type 
A  domains of von Willebrand factor (vWF),  complement 
factor B, and the repeats of chicken cartilage matrix protein 
(CMP).  These similarities suggest relevant functional do- 
mains within the LFA-1 ct subunit as well as novel evolution- 
ary relationships. 
Materials and Methods 
Protein Purification 
The  mAb, TS1/22,  which is directed against the LFA-I  ~  subunit,  was 
purified and coupled using cyanogen bromide to CL-4B Sepharose at 2 mg 
mAb per ml of packed bed. SKW3 cells (42.2 g) were lysed in 300 ml of 
lysis buffer (25)  and the lysate was spun at 5,000 g, the pellet discarded, 
and then spun at  16,000 g for 2 h. The supernatant was then sequentially 
passed through a precolumn of activated and quenched CL-4B Sepharose 
and then a TS1/22 mAb Sepharose column. The TS1/22 column was washed 
sequentially (25), and the LFA-I  molecule was eluted with 0.5  M  NaC1, 
0.1% Triton X-100,  1 mM iodoacetamide, 10 U/ml aprotinin, and 0.025% 
NAN3, 50 mM triethylamine, pH  11.5, and the pH immediately neutral- 
ized. The fractions containing LFA-1 were pooled, lyophilized, and precipi- 
tated in 5 vol ethanol at  -20°C overnight. 
Purified protein was reduced and alkylated (23) and subjected to prepara- 
tive SDS-PAGE. The band corresponding to the ot subunit was visualized 
with 1 M KC1, excised, and electroeluted (20). The purified ~ subunit was 
lyophilized and precipitated in 4 vol ethanol at -20°C overnight. The pellet 
was resuspended and digested with  1%  (wt/wt) trypsin (23).  The tryptic 
fragments were then isolated by HPLC (Beckman Instruments Inc., Palo 
Alto, CA) on a C4 reverse phase column (Vydac, Hesperia, CA). The pep- 
tides were eluted on a 0-60%  acetonitrile gradient in  1%  trifluoroacetic 
acid. Several peaks were rechromatographed isocratically in a concentration 
of acetonitrile determined by the equation, F  =  0.9E-2, where F is the vol- 
ume percentage of acetonitrile under isocratic conditions for a peptide that 
eluted at E percent during the linear gradient (57). Peaks were collected in 
1.5-ml polypropylene tubes and concentrated to <50 #l. Eight peaks were 
subjected to microsequencing. The sequence of one peptide, L64, was used 
to synthesize a single sequence oligonucleotide (5'-GGGATGTTGTGGT- 
CATGGATGGTGGGCTCAAT-3') according to suggestions of Lathe (26). 
cDNA Cloning, Restriction Mapping, and 
Nucleotide Sequencing 
The production and screening of the cDNA library was performed as previ- 
ously described (9).  Restriction maps of the selected clones were deter- 
mined by double and partial digests (28). Restriction fragments were sub- 
cloned  into  either  Ml3mpl8  and  mpl9  (31) or pGEM-3Z,  4Z,  or  7Z 
(Promega Biotec, Madison, Wl). Deletions of the fragments in pGEM were 
made using Exonuclease III and S1 nuclease (18).  Sequencing was by the 
dideoxy  termination  method  (43).  The  coding,  5'-untranslated  and  3'- 
untranslated regions were determined 100, 100, and 36.7 % in both orienta- 
tions, respectively. 
Southern and Northern Blot 
Southern blots were performed as described elsewhere (8).  For Northern 
blots, 10 #g of poly (A+) RNA isolated from SKW3, U937, IB4, or EJ cells 
was subjected to electrophoresis  on a 1.0% formaldehyde gel and transferred 
to nitrocellulose (5). The nitrocellulose (Bio-Rad Laboratories, Richmond, 
CA) was prehybridized and hybridized in 2× SSC, Ix Denhardt's solution, 
0.1% SDS, and  10 p.g/ml of herring sperm DNA. A  1.8-kb Eco RI probe 
from the 5' end of  the cDNA clone, k3R1 (Fig. 2), was labeled by nick trans- 
lation and used as probe. 
Computer Analysis 
Homology searches and alignment of sequences used the Microgenie DNA 
program (Beckman Instruments Inc.), FASTP (56) on the NBRF and NEW 
databases (National Biomedical Research Foundation, Washington, DC), 
and  FASTP  using  the  SWISS-PROT  data  base  (Bionet  Intelligenetics, 
Mountainview, CA). These alignments were then optimized, and the per- 
cent identity and  statistical significance were determined using ALIGN 
(NBRF) (11). 
Hydrophobicity was determined according to Hopp and Woods using the 
Microgenie DNA program (19). 
Results and Discussion 
Protein Purification and Peptide Sequence 
LFA-1 was solubilized from SKW3, a T lymphoma cell line, 
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Residues  Amino acid sequence 
95-107 
199-210 
254-260 
405-413 
494-503 
541-554 
564-576 
803  - 817 
929-946 
XXDQ(N)  TYLSGL(E)YLF 
HMLLLTNTFGAI 
YIIGIGK 
VLLFQEXQG 
GEAITALTXI 
IEGTQVLSGIQXFG 
X(L)  E(G)  D(V/G)  LADVAVGAE 
KVEMLKPHSEIXVS 
I  (E/Q)  P  S  I  H  D  H  N  I  PX  LEAV  XG 
Parentheses indicate  ambiguity in the sequence. The underlined residues were 
used to generate an oligonucleotide probe. 
Figure  1.  Protein  purification  of LFA-1  c~ 
subunit. Silver-stained SDS-PAGE gel show- 
ing a column fraction of the affinity-purified 
protein (lane 1 ) and the electroeluted c~ sub- 
unit (lane 2). 
and isolated by mAb affinity chromatography using an anti- 
body directed against the c~ subunit.  SDS-PAGE showed the 
ot and fl subunits (Fig.  1, lane 1 ). The ~ subunit was further 
purified by preparative SDS-PAGE (Fig.  1, lane 2) and the 
purified o~ subunit was digested with trypsin and the peptides 
were isolated by reverse phase HPLC. The sequence of nine 
peptides was determined by microsequencing (Table I) and 
the  sequence possessing the lowest codon redundancy was 
used to specify a single oligonucleotide sequence which used 
the most commonly occurring human codons (26). 
cDNA Cloning and Characterization 
The  32-mer oligonucleotide probe was used to  isolate 20 
clones from a size-selected Xgtl0 cDNA library constructed 
from PMA-stimulated  myeloid cells (9).  These cells have 
been previously shown to  synthesize the  LFA-1  ct  subunit 
(32). The insert size was determined and the longest clone, 
LSL5, was restriction mapped, and sequenced (Fig. 2). This 
clone contained the  nucleotide  sequence corresponding to 
the oligonucleotide probe (85 % identity to the "best-guess" 
probe)  and  agreed  perfectly  with  the  tryptic  peptide  se- 
quence (16 of 16 residues).  However, this clone did not en- 
code the entire protein since not all of the tryptic peptide se- 
quences  were present  in  the  open  reading  frame.  The  5' 
1.0-kb Eco RI fragment of X5L5 was used to select 14 addi- 
tional clones.  The clone ~,3R1 had an identical  restriction 
map in the overlapping regions and contained an additional 
1.0-kb  5' fragment (Fig.  2). 
The composite sequence of X5L5 and ~,3R1 contains 5,139 
nucleotides (Fig. 3). There is an open reading frame of 3,510 
nucleotides, a 5' untranslated region of 94 nucleotides, and 
a 3' untranslated region of 1,535  nucleotides which contains 
a  polyadenylation  signal  site  15  nucleotides  before  the 
poly(A+) tail.  Within the 3' untranslated  region there is a 
typical  Alul  repeat  consisting  of two  tandem  related  se- 
quences each terminated by an A-rich segment (16). 
Northern blots demonstrate an LFA-1 c~ subunit mRNA of 
5.5  kb in SKW3 T  lymphoma cells,  U937 myelomonocytic 
cells, and IB4 B lymphoblastoid cells (Fig. 4 A, lanes 1-3); 
however,  no  signal  was detected  in  EJ bladder carcinoma 
cells (Fig. 4 A, lane 4). The mRNA expression is in agree- 
ment with the restriction of cell surface expression of LFA-1 
to hematopoietic cells. The fl subunit showed the same pat- 
tern of expression (Fig. 4 B).  In Southern blots, the  1.2-kb 
5' Eco RI-Bam HI fragment from clone X2L2 hybridized to 
two fragments of 10 and 8 kb (8). A genomic clone isolated 
from a  cosmid  library possesses the  same two  fragments 
1.0 kb 
q  ! 
13R1 
131  P SC P  NC  I~B  P  P  R  P  S  P  Ba  P  PBa 
l  T  T  l  T  I  '11  l  T  '  T  T  'T 
Sp 
f 
ID  ~'4.-  ql  II 
~.5).5 
Figure 2. Restriction map of the LFA-1 c~ subunit 
cDNA clones.  The open  reading  frame and un- 
translated regions are indicated with a thick and 
thin line,  respectively. Arrows indicating the se- 
quencing strategy are shown. The relevant restric- 
tion sites are Bal I (BI), Bam HI (Ba), Bgl II (B), 
Cla I (C), Eco [] (R),  Nru I (N),  Pst I (P), Sca 
I (Sc), Sma (S), and Sph I (Sp). 
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~~~~~~~~~~~~~3~ 
D  PPRAGRHFGYRVLQVGNGVIVGAPGEG~GSLYQCO 
~~~~~~~~~~~~~4~ 
SGTGHCLPVTLRGS~YTISKYLGMTLATDPTDGSILAC 
~~~~~~~~~~~~~5~ 
DPGLSRTCD~NTYLSGLCYLFRONLQGPMLQGRPGFQ 
~~~~~~~~~~~~~9 
~4  ECIKGNVDLVFLFDGSMSLQPDEFQKILDFMKDVMKK 
~~~~~~~~~~~~C~7~ 
161  LS~'~--~YQFAAVOFSTSYKTEFDFSDYVKWKDPDALLK 
HVKHMLLLTNTFGAINYVATEVFREELGARPDATKVL 
~~~~~~~~~~~~~9~ 
~5IIITDGEATDSGNIDAAKDIIRYIIGIGKHFQTKESQ 
~~~~~~~~~~~~~1~3 
ETLHKFASKPASEFVKILDTFEKLKDLFTELQKKIYV 
~~~~~~~~~~~~~1204 
IEGTSKQDLTSFNMELSSSGISADLSRGHAVVGAVGA 
~~~~~~~~~~~~~1315 
~6  KDWAGGFLDLKADLQDDTFIGNEPLTPEVRAGYLGYT 
~~~~~~~~~~~~~1426 
VTWLPSRQKTSLLASGAPRYQHMGRVLLFQEPQGGGH 
~~~~~~~~~~~~~15~ 
~0WSQVQTIHGTQIGSYFGGELCGVDVDQDGETELLLIG 
4~  APLFYGEQRGGRVFIYQRRQLGFEEVSELQGDPGYPL 
~~~~~~~~~~~~T1759 
4~  GRFGEAITALTDINGDGLVDVAVGAPLEEQGAVYIFN 
~~~~~~~~~~~~~1872 
~i  GRHGGLSPQPSQRIEGTQVLSGIQWFGRSIHGVKDLE 
~~~~~~~~~~~~~1981 
~SGDGLADVAVGAESQMIVLSSRPVVDMVTLMSFSPAEI 
~5pVHEVECSYSTSNKMKEGVINI~ICFQIKSLYPQFQGR 
~~~~~~~~~~~~~2203 
~2  LVA~'~m"~YTLQLDGHRTRRRGLFPGGRHELRRNIAVTT 
~~~~~~~~~~~~~23~ 
~9  SMSCTDFSFHFPVCVQDLISPI~"V---~L~"~'~LWEEEGTP 
~~~~~~~~~~~~T2425 
716  RDQRAQGKDIPPILRPSLHSETWEIPFEKNCGEDKKC 
~~~~~~~~~~~~A~  25~ 
753  EANLRVSFSPARSRALRLTAFASLSVELSLSNLEEDA 
7~  YWVQLDLHFPPGLSFRKVEMLKPHSQIPVSCEELPEE 
~~~~~~~~~~~~~2758 
~7  SRLLSRALSC~-~"~--~SPIFKAGHSVALQMMFNTLV~-"~--~W 
~~~~~~~~~~~~A~A~2869 
GDSVELHA[~"V--'~CNNEDSDLLEDNSATTIIPILYPINI 
~~~~~~~~~~~~~29~ 
~1  LIQDQEDSTLYVSFTPKGPKIHQVKHMYQVRIQPSIH 
~~~~~~~~~~~~~3091 
~SDHNIPTLEAVVGVPQPPSEGPITHQWSVQMEPPVPCH 
~SYEDLERLPDAAEPCLPGALFRCPVVFRQEILVQVIGT 
10~LELVGEIEASSMFSLCSSLSISF~KHFHLYGS~--"~'~ 
i~9  L  A  Q  V  V  M  K  V  D  V  V  Y  E  K  Q  M  ~_:y  L_.  ¥  _V  ~  ~_  G  I_. G  G_  L  ~_  L  .~_  L  ~_  I  .L:I 
10~_~.__.~..._~__..~.._R__.~....~_KRNLKEKMEAGRGVPNGIPAED~EQLA~GQ  ....................................... 
I~EAGDPGCLKPLHEKD~E~GGGKD 
3808 
~"i"  -ICIbI'I~I-II'I'I~'IG~F~C~G'IL~I  "  -I-iL-I  3956 
41~ 
~L  "  -IUIt~I'I~L'~  ~  4252 
~'~4400 
~  4~4 
509 
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ysis of 10 #g of poly (A+)  se- 
lected RNA from SKW3 (lane 1 ), 
U937 (lane 2), IB4 (lane 3), and 
EJ  cells  (lane  4).  (B) Identical 
blot reprobed with the/~ subunit 
cDNA probe (23).  The position 
of the 28 and 18 S rRNA is indi- 
cated. 
which are contiguous and hybridize with different regions of 
the  cDNA  (unpublished  data)  showing  that  the  LFA-1  ct 
subunit is a  single copy gene. 
Protein Sequence 
All 105 amino acids determined by microsequencing of tryp- 
tic peptides were found in the translated open reading frame, 
confirming the  authenticity  of the  cDNA clones  (Fig.  3). 
Hydrophobicity analysis shows that the LFA-1 o~ subunit is 
a  typical transmembrane protein with a  25-residue hydro- 
phobic  signal  sequence,  an  extracellular domain  of  1,063 
residues, a single hydrophobic transmembrane region of 29 
residues,  and a  short cytoplasmic tail of 53  residues.  The 
NH2-terminal residue of human LFA-1 was identified by ho- 
mology to the NH2-terminal sequence of murine LFA-I (48) 
(Fig. 6, see below). Human LFA-1 has 55 % identity with mu- 
rine LFA-1 over the first 20 amino acids. A  classical signal 
peptide with a consensus sequence (Ala-X-Ser/Pro) for the 
cleavage  peptidase  precedes  the  NH2-terminal  sequence. 
There  are  three  putative  upstream  transcription  initiation 
sites  (ATG)  in  frame.  The  use  of the  first  initiation  site 
2. These data sequence have  been submitted  to the EMBL/GenBank  Data 
Libraries under the accession number Y00796. 
(nucleotide position 89) is generally favored (24) and gives 
a  25-residue  signal  sequence  with  several  NH2-terminal 
polar groups as is typically found in signal sequences (54). 
The mature protein is Mr  =  126,193.  12 N-linked glyco- 
sylation sites (Asn-X-Thr/Ser) are present in the extracellular 
domain.  These findings are consistent with the size previ- 
ously determined by SDS-PAGE for the in vitro translated 
murine  LFA-1 ~  subunit  (Mr  =  140,000),  the  murine and 
human LFA-1 o~ subunit  glycoproteins (Mr  =  180,000  and 
177,000) (44), and with previous studies on the glycosylation 
of LFA-1 (10, 32). 
Within  the extracellular domain there are seven internal 
repeats (Fig. 5). The degree of identity is highest among the 
three repeats (14.5-33 %) located toward the COOH termi- 
nus which show a  statistically significant relationship (P < 
10  -2- <  10-6). The relationship among the four repeats lo- 
cated toward the NH2 terminus is weaker and is discernible 
by conservation of flanking sequences (Fig.  5);  the homol- 
ogy between repeat IV and V  is significant (P <  10-4). The 
central regions of the three COOH-terminal repeats is simi- 
lar with the EF hand divalent cation binding site motif, per- 
haps due to convergent evolution (Fig.  5).  Previous studies 
have  shown  that  Mg  2+  alone or  at  lower concentration  in 
conjunction with Ca  2+ is necessary for ligand binding func- 
Figure 3. Nucleotide sequence and derived protein sequence of the c~ subunit of LFA-1.  2 The potential glycosylation sites are boxed. The 
sequences of the tryptic peptides and the transmembrane  region are underlined  with a thick and shaded line, respectively. The putative 
serine phosporylation  sites are circled.  The nucleotides in the 3' untranslated region that are underlined correspond  to an Alul  sequence 
and the polyadenylation site is boxed. 
Larson et al. Molecular Cloning of LFA-I c~ Subunit  707 Flanking ....  sequence  (LFA-I)  :  Y~LG y S~V  ..............  %AVGAP 
Flanking omusensus sequence (Integrlns)  :  S Y F G - S V ..............  L V V G A P 
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VI  484  E Ll_q  GTD. r'lGI ¥  t' LLq..~JSI  F GI  E Mr~  LT- DI I  Nl'fft~ a L'L~VIS]'T]V'A"V'~  A__P  L ~__~Lq]- -  - q~lAqV 171!Iv N G a~J a  GIG~I~b] 0  P S 0 
Vn  543  R I  EIG~o V L S G I  0  wl~ GIR S  I~./]-ff~.~lt~lL FIG D GLA'p.J-lv A V G A~  -  0  M I  V L S~V~D  M V r  b M~A  E I 
dlvale~t cation bi~dlng site consensus 
dival~t cation coordination sites 
D-DG~NG-ID--E 
+X  +Y  +Z  -Y  -X  -Z 
dlval~t cation binding sites 
Parvalbtl~n  CD  51  DEDKSGFIEEDE 
90  DSDGDGKIGVDE 
Troponln C  27  DADGGGDI  SVKE 
63  DEDGSGTIDFEE 
103  DRNADGYIDPEE 
139  DKNNDGRI  DFDE 
Galactose Binding  134  D L N K D G Q I Q - I E* 
Protein 
54 
107 
366 
421 
483 
542 
604 
Figure 5. Alignment of the internal repeats of the LFA-1 ~ subunit. The consensus flanking sequence is shown above the aligned repeats. 
Consensus residues were defined as those appearing in at least 30% of the integrin a subunits analyzed (Mac-1 [4, 7], p150,95 [9], vitronec- 
tin receptor [50], fibronectin receptor [3], and platelet glycoprotein lib [37]). The calcium and magnesium binding sites of parvalbumin, 
troponin C (52), and galactose binding protein (55) are aligned as shown. The asterisk indicates that more than one oxygen is involved 
in cation binding. 
tion  (29)  (Dustin,  M.  L.,  and  T.  Springer  unpublished 
results),  suggesting that these sites bind divalent cations. 
Distinct Subfamilies of lntegrin ~ Subunits 
We  compared  the  LFA-1  ~  subunit  to  other  integrin  c~ 
subunits (Fig. 6). The LFA-1 c~ subunit has striking and con- 
sistently  higher  homology  to  other  leukocyte  integrin  c~ 
subunits (Mac-l,  35.7%;  p150,95,  37.4%) than to ECM re- 
ceptor  integrin  c~  subunits  (vitronectin  receptor,  26.4%; 
FNR, 27.8%; gpIIb 30.2%).  The ECM receptor integrin c¢ 
subunits are more related to one another (~ =  41.9% SD  = 
3.7%)  than  to the leukocyte integrins  (Fig.  8,  see below). 
Further  structural  features  distinguish  the  leukocyte  and 
ECM receptor integrins. The leukocyte integrins contain an 
insertion of ~  200 amino acids  near the  NH2-terminal re- 
gion of the protein that is not present in the three sequenced 
ECM receptor integrins (Fig. 6). Furthermore, a region con- 
taining dibasic amino acid protease cleavage sites in vitro- 
nectin receptor, FNR,  and gpIIb/IIIa (residues 853-871)  is 
absent from LFA-1 as well as p150,95  and Mac-1 c~ subunits, 
correlating with the lack of proteolytic processing of the leu- 
kocyte integrin c~ subunits (42). As a whole, these structural 
features define two subfamilies of the c~ subunit integrins, the 
leukocyte integrins and the ECM receptor integrins. 
All the integrin ~ subunits thus far sequenced have tandem 
repeats similar to those of LFA-1 (3,  9,  37, 41,  51) (Fig.  5). 
Putative divalent cation binding sites are present in repeats 
V-VII in all the integrin c~ subunits and in repeat IV only in 
the ECM receptor integrins. These sites are similar to the EF 
hand divalent cation binding sites located in the turn between 
two c~ helices in troponin C, parvalbulmin (52), and galac- 
tose binding protein (55) among others. In the EF hand loop 
the metal is chelated to six oxygen-containing side groups 
spaced every second or third residue. The putative divalent 
cation binding sites on LFA-1 and the other integrins have a 
similar primary structure with the putative chelating  resi- 
dues and intervening glycine residues being conserved (Fig. 
5).  However, the residue in the  -Z  position is replaced by 
a  hydrophobic residue. 
An Inserted Domain in the Leukocyte Integrins 
Searches of the NBRF and SWISS-PROT protein sequence 
data banks revealed that the LFA-1 domain of '~ 200 amino 
acids, which is not present in the sequenced ECM integrins, 
is homologous to the domains of the same size in vWF and 
a cartilage matrix protein (Figs. 7 and 8). These alignments 
have 20.4-32.1%  identity and are statistically significant (P 
<  10  -9- <  10-23).  Of the  integrins  sequenced  to  date,  this 
200-amino acid domain is unique to the leukocyte integrins. 
Homologous domains are inserted in several proteins and in 
well-studied examples have been documented to mediate in- 
teraction with ligand (see below). For this reason we will re- 
fer  to  the  200-residue  region  of the  LFA-1, Mac-l,  and 
p150,95  a  subunits as the "I" (inserted/interactive) domain. 
The homology unit is present in three tandem repeats in vWF 
(A domains) (45) (P <  10  -~s- <  10  -23 for comparison of the 
three repeats to one another) and two repeats separated by 
an EGF domain in CMP (2) (P <  10-23). With the exception 
of the NH2-terminal region of the CMP repeat 1 which has 
not been sequenced,  the repeating units  in both vWF and 
CMP correspond precisely to the region homologous to the 
I domain, supporting the concept that this homology unit is 
a domain. Similar structural homologies have been noted for 
the murine and human Mac-1 c~ subunit (7, 38) and the de- 
gree of homology of Mac-1 and p150,95 with vWF and CMP 
is similar to that found with LFA-1 (17.8-31.6%  identity, P 
<  10  -9- <  10-23). Factor B has previously been found to be 
homologous  with  the  vWF  A  repeats  (P <  10  -4- <  10 -7) 
(45); factor B in turn is homologous but at a lower level with 
the LFA-1, Mac-l, and p150,95  I domains (P <  10  -2- <  10  -4) 
(7, 38). In factor B a single homology unit is bounded on one 
side by the site for the cleavage which activates the B zymo- 
gen to the active Bb fragment, and on the other side by the 
serine protease domain (6). 
Based  on  these  homologies,  we  propose  the  following 
pathway for leukocyte integrin evolution. A primordial gene 
duplicated and gave rise to at least two branches of integrin 
a  subunits,  the  leukocyte integrins and the ECM  integrin 
receptors. The percent identity among the I domains is very 
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Figure 6.  Alignment and comparison of the human LFA-I ~  subunit with the other membe~ of the integrin super~mily (Mac-1  [4, 7], 
p150,95  [9],  vitronectin receptor [50],  fibronectin recep~r [31, and platelet glycopro~in IIb [37]  and the NH~ ~rminus  of the murine 
LFA-1  ~  subunit  [48].  The residues common ~  LFA-I and at least one other in,grin are boxed.  The area of the I domain is shown in 
Fig. Z  The pro~ase cleavage si~ in the ECM receptor a  subunits  are indicated with black dots. 
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Figure 7. Alignment and comparison of the LFA-1 tx subunit I domain with the homologous domains in Mac-1 (4, 7), p150,95 (9), vWF 
(45), factor B (34), and CMP (3). 
similar to the overall percent identity among the leukocyte 
integrins, implying that a single I domain incorporated into 
a  primordial leukocyte integrin only once rather than in- 
dependently. Then, the gene duplicated and gave rise to LFA- 
1 and a Mac-1/p150,95  primordial gene. Further duplication 
of the Mac-1/p150,95  primordial gene gave rise to Mac-1 and 
p150,95.  This scheme is consistent with the observation that 
Mac-1  and p150,95  are more closely related to each other 
(61.0%)  than  to  LFA-1 (35.7, 37.4%,  respectively).  Since 
LFA-1, Mac-l, and p150,95  ot subunits are located on chro- 
mosome 16 band pll (8), these ot subunits genes remained 
in close proximity. ECM ct subunits appear to be a separate 
branch since they are more closely related to each other than 
to the leukocyte integrins even ignoring the I domain (Fig. 
8). Although three sequenced o~ subunits of ECM integrins 
bind  to  two different /3  subunits,  the  two  ct  subunits  as- 
sociated with the/33 subunit are not more closely related to 
one another than to the a  subunit associated with the/3, 
subunit.  Thus, although there are three distinct/3 subunits, 
only two subfamilies of a  subunits can be distinguished by 
sequence homology considerations. The structural proper- 
ties of the leukocyte integrin o~ subunits may not be unique 
to their subfamily since some VLA integrin ct subunits may 
have a homologous I domain and lack a proteolytic cleavage 
site (Hemler, M.  personal communication). 
The I domain appears to be incorporated in proteins which 
are otherwise structurally distinct. These structurally simi- 
lar domains form an important protein superfamily which we 
will designate the I domain superfamily. Repeats within vWF 
and within CMP are internally more related than to the do- 
mains in other proteins (Fig. 8). Thus, it appears a single do- 
main was  incorporated and then duplicated or triplicated. 
Members of  the I domain superfamily serve important recog- 
nition functions in several proteins. The A1 domain of vWF 
binds to glycoprotein Ib and heparin (15) while both the A1 
and A3 domains are involved in binding to collagen. The do- 
main in factor B is located in a region of the molecule avail- 
able for interaction with its ligand C3b (6, 34). The domain 
in CMP may also have an important role in interaction with 
collagen (2) and cartilage proteoglycan (35). These domains 
lack glycosylation and cysteines for the most oart. Similarly, 
the I  domain and the repeats with divalent cadcu binding 
sites in LFA-1 contain only one N-glycosylation site and cys- 
teine (Fig. 8). Similar to the Mac-1  (7, 38) and p150,95  (9) 
t~ subunits,  the N-glycosylation sites and cysteines are lo- 
cated primarily NH2-terminal and COOH-terminal to this 
region. Therefore, the I domain would be accessible to ligand 
and capable of conformational changes which may be impor- 
tant in regulation of ligand binding (39). 
Structural differences between the ECM receptor integrin 
a  subunits and LFA-1 correlate with differences in recogni- 
tion specificity; RGD containing peptides block the binding 
of the VNR, FNR, and gplIb/IIIa to their ligands (41) but not 
binding of LFA-1 to ICAM-1  (29).  Furthermore, ICAM-1 
The Journal of Cell Biology, Volume  108, 1989  710 Figure 8. Schematic represen- 
tation of the evolutionary re- 
lationships  of the domains ho- 
mologous  to  the  I  domain. 
Black  lollipops  (above  sche- 
matic) and circles (below sche- 
matic)  indicate  the respective 
sites of potential glycosylation 
and  cysteines  within  LFA-I. 
The percent  identity  and the 
standard deviations among the 
different  integrin  et  subunits 
and members of the I domain 
superfamily  are  shown.  Se- 
quences were compared pair- 
wise  using  the  ALIGN pro- 
gram. The I domain sequences 
were as follows: LFA-1,  Mac-l, 
and p150,95 c~ subunits  (130- 
327;  133-337;  131-335, re- 
spectively),  the A  repeats  of 
von  Willebrand  factor  (AI: 
513-717;  A2:  734-922;  A3: 
927-1115), factor B (245-450), 
and  collagen  matrix  protein 
(repeat  I:  1-167; repeat  2: 
195-393).  Relevant probabil- 
ity  values  are  shown  in  the 
text. 
does not contain an RGD sequence and unlike other known 
integrin ligands,  is a  member of the immunoglobulin gene 
superfamily. It will be of interest to determine whether the I 
domain confers specificity for non-RGD containing ligands. 
This study demonstrates that the LFA-I c~ subunit belongs 
to the integrin  superfamily but possesses an additional  do- 
main.  This I domain and homologous domains constitute a 
protein  "domain"  family  that  is  of functional  importance. 
Since LFA-1 is involved in a large number of leukocyte func- 
tions and may have more than one ligand (39) (Dustin, M.  L., 
and T. Springer, manuscript in preparation), it is possible the 
more than one functional domain exists in the LFA-1 ot sub- 
unit.  The availability of cDNA clones for the ~  and/~ sub- 
units will allow these and other structure-function relation- 
ships  to be examined. 
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